LEGACY HEALTHCARE INVESTMENTS : revenue, balance sheet and financial ratios

LEGACY HEALTHCARE INVESTMENTS is a French company founded 10 years ago, specialized in the sector Activités des sociétés holding. Based in PARIS (75006), this company of category ETI shows in 2024 a revenue of 5.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LEGACY HEALTHCARE INVESTMENTS (SIREN 821889011)
Indicator 2024 2023 2022 2021 2017 2016
Revenue 5 443 088 € 5 256 912 € 5 040 765 € 4 499 539 € 1 000 000 € N/C
Net income 4 815 049 € 5 657 390 € 3 441 029 € 2 283 608 € 2 994 489 € -8 861 €
EBITDA 1 583 894 € 1 986 698 € 1 325 915 € 1 550 081 € 44 685 € -8 861 €
Net margin 88.5% 107.6% 68.3% 50.8% 299.4% N/C

Revenue and income statement

In 2024, LEGACY HEALTHCARE INVESTMENTS achieves revenue of 5.4 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +27.4%. Vs 2023: +4%. After deducting consumption (0 €), gross margin stands at 5.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.6 M€, representing 29.1% of revenue. Warning negative scissor effect: despite revenue change (+4%), EBITDA varies by -20%, reducing margin by 8.7 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 4.8 M€, i.e. 88.5% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

5 443 088 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

5 443 088 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 583 894 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 583 857 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

4 815 049 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

29.1%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 88.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.33%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

50.662%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

88.464%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.003

Solvency indicators evolution
LEGACY HEALTHCARE INVESTMENTS

Sector positioning

Debt ratio
0.33 2024
2022
2023
2024
Q1: 0.01
Med: 8.77
Q3: 62.6
Good -17 pts over 3 years

In 2024, the debt ratio of LEGACY HEALTHCARE INVESTM... (0.33) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
50.66% 2024
2022
2023
2024
Q1: 15.71%
Med: 62.26%
Q3: 91.3%
Average

In 2024, the financial autonomy of LEGACY HEALTHCARE INVESTM... (50.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.09 years
Q3: 3.07 years
Good -24 pts over 3 years

In 2024, the repayment capacity of LEGACY HEALTHCARE INVESTM... (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 198.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.0x. Coverage is limited: any activity downturn would jeopardize interest payments.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

198.231

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

1.021

Liquidity indicators evolution
LEGACY HEALTHCARE INVESTMENTS

Sector positioning

Liquidity ratio
198.23 2024
2022
2023
2024
Q1: 138.65
Med: 681.09
Q3: 3914.52
Average

In 2024, the liquidity ratio of LEGACY HEALTHCARE INVESTM... (198.23) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
1.02x 2024
2022
2023
2024
Q1: -74.77x
Med: 0.0x
Q3: 0.0x
Excellent

In 2024, the interest coverage of LEGACY HEALTHCARE INVESTM... (1.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 343 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 285 days. The gap of 58 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 332 days of revenue, i.e. 5.0 M€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

5 023 644 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

343 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

285 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

332 j

WCR and payment terms evolution
LEGACY HEALTHCARE INVESTMENTS

Positioning of LEGACY HEALTHCARE INVESTMENTS in its sector

Comparison with sector Activités des sociétés holding

Valuation estimate

Based on 54 transactions of similar company sales in 2024, the value of LEGACY HEALTHCARE INVESTMENTS is estimated at 6 197 115 € (range 2 143 101€ - 14 934 904€). With an EBITDA of 1 583 894€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.59x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
54 tx
2143k€ 6197k€ 14934k€
6 197 115 € Range: 2 143 101€ - 14 934 904€
NAF 5 année 2024

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 583 894 € × 4.8x
Estimation 7 659 474 €
1 296 561€ - 13 199 509€
Revenue Multiple 30%
5 443 088 € × 0.59x
Estimation 3 204 736 €
1 993 751€ - 3 809 827€
Net Income Multiple 20%
4 815 049 € × 1.5x
Estimation 7 029 788 €
4 483 480€ - 35 961 009€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sociétés holding)

Compare LEGACY HEALTHCARE INVESTMENTS with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sociétés holding

Frequently asked questions about LEGACY HEALTHCARE INVESTMENTS

What is the revenue of LEGACY HEALTHCARE INVESTMENTS ?

The revenue of LEGACY HEALTHCARE INVESTMENTS in 2024 is 5.4 M€.

Is LEGACY HEALTHCARE INVESTMENTS profitable?

Yes, LEGACY HEALTHCARE INVESTMENTS generated a net profit of 4.8 M€ in 2024.

Where is the headquarters of LEGACY HEALTHCARE INVESTMENTS ?

The headquarters of LEGACY HEALTHCARE INVESTMENTS is located in PARIS (75006), in the department Paris.

Where to find the tax return of LEGACY HEALTHCARE INVESTMENTS ?

The tax return of LEGACY HEALTHCARE INVESTMENTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LEGACY HEALTHCARE INVESTMENTS operate?

LEGACY HEALTHCARE INVESTMENTS operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.